Role of the Renin-Angiotensin System in Vascular Diseases: Expanding the Field
Open accessThe DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
The renin-angiotensin system (RAS) has emerged as one of the essential links in the pathophysiology of vascular disease. Angiotensin (Ang) II, the main peptide of the RAS, was considered as a vasoactive hormone, but in the past years, this view has been modified to a growth factor that regulates cell proliferation/apoptosis and fibrosis. Recently, this view has been enlarged with a novel concept: Ang II participates in the inflammatory response, acting as a proinflammatory mediator. In resident vascular cells, Ang II produces chemokines, cytokines, and adhesion molecules, which contribute to the migration of inflammatory cells into the tissue injury. Ang II is also a chemotactic and mitogenic factor for mononuclear cells. The molecular mechanisms of Ang II–induced vascular damage are mediated by the activation of transcription factors, redox signaling systems, and production of endogenous growth factors. In addition, other components of the RAS could also be involved in the pathogenesis of cardiovascular diseases. The Ang II degradation product Ang III shares some of its properties with Ang II, including chemotaxis and production of growth factors and chemokines. All these data clearly demonstrate that Ang II is a true cytokine, show the complexity of the RAS in pathological processes, and provide some mechanistic responses of the beneficial effects of the treatment with RAS blockers in cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Boring, L., Gosling, J., Cleary, M., & Charo, I. F. (1998) · Nature · doi:10.1038/29788 · Cited by 1,965
Mancini, G. B. J., Henry, G. C., Macaya, C., O'Neill, B. J., Pucillo, A. L., Carere, R. G., Wargovich, T. J., Mudra, H., Lu¨scher, T. F., Klibaner, M. I., et al. (1996) · Circulation · doi:10.1161/01.cir.94.3.258 · Cited by 1,057
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839
Schieffer, B., Schieffer, E., Hilfiker-Kleiner, D., Hilfiker, A., Kovanen, P. T., Kaartinen, M., Nussberger, J., Harringer, W., & Drexler, H. (2000) · Circulation · doi:10.1161/01.cir.101.12.1372 · Cited by 654
Angiotensin II and Renal Fibrosis
Mezzano, S. A., Ruiz-Ortega, M., & Egido, J. (2001) · Hypertension · doi:10.1161/hy09t1.094234 · Cited by 523
Self-citationHernández-Presa, M., Bustos, C., Ortego, M., Tuñon, J., Renedo, G., Ruiz-Ortega, M., & Egido, J. (1997) · Circulation · doi:10.1161/01.cir.95.6.1532 · Cited by 494
Self-citationAngiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Pathophysiological Role of Angiotensin II Type 2 Receptor in Cardiovascular and Renal Diseases
Matsubara, H. (1998) · Circulation Research · doi:10.1161/01.res.83.12.1182 · Cited by 478
Increased Accumulation of Tissue ACE in Human Atherosclerotic Coronary Artery Disease
Diet, F., Pratt, R. E., Berry, G. J., Momose, N., Gibbons, G. H., & Dzau, V. J. (1996) · Circulation · doi:10.1161/01.cir.94.11.2756 · Cited by 426
Proinflammatory actions of angiotensins
Ruiz-Ortega, M., Lorenzo, O., Suzuki, Y., Rupérez, M., & Egido, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200105000-00005 · Cited by 412
Self-citationChen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.9.952 · Cited by 385
Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 379
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Angiotensin II Induces Apoptosis of Human Endothelial Cells: Protective Effect of Nitric Oxide
Dimmeler, S., Rippmann, V., Weiland, U., Haendeler, J., & Zeiher, A. M. (1997) · Circulation Research · doi:10.1161/01.res.81.6.970 · Cited by 373
Weiss, D., Kools, J. J., & Taylor, W. R. (2001) · Circulation · doi:10.1161/01.cir.103.3.448 · Cited by 368
Wang, H. D., Xu, S., Johns, D. G., Du, Y., Quinn, M. T., Cayatte, A. J., & Cohen, R. A. (2001) · Circulation Research · doi:10.1161/hh0901.089987 · Cited by 344
Ortego, M., Bustos, C., Hernández-Presa, M. A., Tuñón, J., Dı́az, C., Hernández, G., & Egido, J. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00193-8 · Cited by 343
Self-citationRuiz-Ortega, M., Lorenzo, O., Rupérez, M., König, S., Wittig, B., & Egido, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1266 · Cited by 331
Self-citationPurcell, N. H., Tang, G., Yu, C., Mercurio, F., DiDonato, J. A., & Lin, A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111155798 · Cited by 323
Human Connective Tissue Growth Factor Is Expressed in Advanced Atherosclerotic Lesions
Oemar, B. S., Werner, A., Garnier, J.-M., Do, D.-D., Godoy, N., Nauck, M., Ma¨rz, W., Rupp, J., Pech, M., & Lu¨scher, T. F. (1997) · Circulation · doi:10.1161/01.cir.95.4.831 · Cited by 296
Ruiz‐Ortega, M., Bustos, C., Hernández-Presa, M. Á., Lorenzo, Ó., Plaza, J. J. G., & Egido, J. (1998) · PubMed · Cited by 284
Self-citationGupta, S., Clarkson, M. R., Duggan, J., & Brady, H. R. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00301.x · Cited by 283
Wolf, G., Ziyadeh, F. N., Thaiss, F., Tomaszewski, J., Caron, R. J., Wenzel, U., Zahner, G., Helmchen, U., & Stahl, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119615 · Cited by 253
Pastore, L., Tessitore, A., Martinotti, S., Toniato, E., Alesse, E., Bravi, M. C., Ferri, C., Desideri, G., Gulino, A., & Santucci, A. (1999) · Circulation · doi:10.1161/01.cir.100.15.1646 · Cited by 249
Ruiz-Ortega, M., Bustos, C., Hernández-Presa, M. A., Lorenzo, O., Plaza, J. J., & Egido, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.430 · Cited by 230
Self-citationMonocyte Chemoattractant Protein-1 Expression in Aortic Tissues of Hypertensive Rats
Capers, Q., Alexander, R. W., Lou, P., Leon, H. D., Wilcox, J. N., Ishizaka, N., Howard, A. B., & Taylor, W. R. (1997) · Hypertension · doi:10.1161/01.hyp.30.6.1397 · Cited by 222
Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages
Okamura, A., Rakugi, H., Ohishi, M., Yanagitani, Y., Takiuchi, S., Moriguchi, K., Fennessy, P. A., Higaki, J., & Ogihara, T. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917040-00012 · Cited by 221
Vasoactive hormones and renal sclerosis
Egido, J. (1996) · Kidney International · doi:10.1038/ki.1996.82 · Cited by 198
Self-citationThe role of vasoactive compounds, growth factors and cytokines in the progression of renal disease
Klahr, S., & Morrissey, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.07509.x · Cited by 194
Brasier, A. R., Jamaluddin, M., Han, Y., Patterson, C., & Runge, M. S. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007133710837 · Cited by 181
Angiotensin II and atherosclerosis
Weiss, D., Sorescu, D., & Taylor, W. R. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01539-9 · Cited by 180
Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
Nakamura, S., Nakamura, I., Ma, L., Vaughan, D. E., & Fogo, A. B. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00160.x · Cited by 178
Ruiz-Ortega, M., Lorenzo, Ó., Rupérez, M., Blanco, J., & Egido, J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64130-2 · Cited by 176
Self-citationPiqueras, L., Kubes, P., Alvarez, A., O’Connor, E., Issekutz, A. C., Esplugues, J. V., & Sanz, M.-J. (2000) · Circulation · doi:10.1161/01.cir.102.17.2118 · Cited by 161
Bush, E., Maeda, N., Kuziel, W. A., Dawson, T. C., Wilcox, J. N., DeLeon, H., & Taylor, W. R. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.360 · Cited by 160
Gräfe, M., Auch–Schwelk, W., Zakrzewicz, A., Regitz‐Zagrosek, V., Bartsch, P., Graf, K., Loebe, M. M., Gaehtgens, P. A. L., & Fleck, E. (1997) · Circulation Research · doi:10.1161/01.res.81.5.804 · Cited by 149
Synthesis and effects of active fragments of angiotensin II
Ardaillou, R., & Chansel, D. (1997) · Kidney International · doi:10.1038/ki.1997.476 · Cited by 142
Hernández-Presa, M. Á., Bustos, C., Ortego, M., Tuñón, J., Ortega, L. M., & Egido, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65697-0 · Cited by 124
Self-citationRuiz‐Ortega, M., Lorenzo, Ó., & Egido, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00089.x · Cited by 117
Self-citationAngiotensin II Increases Monocyte Binding to Endothelial Cells
Kim, J. A., Berliner, J. A., & Nadler, J. L. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1441 · Cited by 117
Cytokine Actions of Angiotensin II
Sadoshima, J. (2000) · Circulation Research · doi:10.1161/01.res.86.12.1187 · Cited by 117
Sakamoto, H., Aikawa, M., Hill, C. C., Weiss, D., Taylor, W. R., Libby, P., & Lee, R. T. (2001) · Circulation · doi:10.1161/hc2701.091070 · Cited by 93
Ruiz‐Ortega, M., Lorenzo, Ó., Rupérez, M., Suzuki, Y., & Egido, J. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.suppl_1.27 · Cited by 87
Self-citationPrasad, A., Koh, K. K., Schenke, W. H., Mincemoyer, R., Csákó, G., Fleischer, T. A., Brown, M., Selvaggi, T. A., & Quyyumi, A. A. (2001) · American Heart Journal · doi:10.1067/mhj.2001.116699 · Cited by 68
Lorenzo, Ó., Ruiz‐Ortega, M., Esbrit, P., Rupérez, M., Ortega, A., Santos, S., Blanco, J., Ortega, L. M., & Egido, J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000015622.33198.bf · Cited by 60
Self-citationNakamura, A., Johns, E. J., Imaizumi, A., Yanagawa, Y., & Kohsaka, T. (1999) · Cytokine · doi:10.1006/cyto.1999.0488 · Cited by 58
Ruiz‐Ortega, M., Lorenzo, Ó., & Egido, J. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06811.x · Cited by 45
Self-citationRuiz‐Ortega, M., Lorenzo, Ó., Rup�rez, M., Esteban, V., Mezzano, S. A., & Egido, J. (2001) · KARGER eBooks · doi:10.1159/000060153 · Cited by 44
Self-citationPreactivated monocytes from hypertensive patients as a factor for atherosclerosis?
Dörffel, Y. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00674-2 · Cited by 42
Regulation of matrix proteins and impact on vascular structure
Tuñón, J., Ruiz‐Ortega, M., & Egido, J. (2000) · Current Hypertension Reports · doi:10.1007/s11906-000-0067-2 · Cited by 41
Self-citationInfluence of angiotensin II on circulating adhesion molecules and blood leukocyte count in vivo
Krejcy, K., Eichler, H., Jilma, B., Kapiotis, S., Wolzt, M., Zanaschka, G., Gasic, S., Schütz, W., & Wagner, O. F. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-218 · Cited by 29
Angiotensin III Is a New Chemoattractant for Polymorphonuclear Leukocytes
Yamamoto, Y., Yamamguchi, T., Shimamura, M., & Hazato, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1729 · Cited by 20
Rigby, S. L., Hofmann, P. A., Zhong, J., Adams, H. R., & Rubin, L. J. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.2.h580 · Cited by 20
Angiotensin II–Stimulated Vascular Remodeling: The Search for the Culprit Oxidase
Irani, K. (2001) · Circulation Research · doi:10.1161/hh0901.091205 · Cited by 18
Cited by
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
The clinical implications of endothelial dysfunction
Widlansky, M. E., Gokce, N., Keaney, J. F., & Vita, J. A. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00994-x · Cited by 1,749
Muka, T., Oliver-Williams, C., Kunutsor, S., Laven, J. S. E., Fauser, B. C. J. M., Chowdhury, R., Kavousi, M., & Franco, O. H. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2415 · Cited by 826
Dandona, P., Dhindsa, S., Ghanim, H., & Chaudhuri, A. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002101 · Cited by 386
Haschke, M., Schuster, M., Poglitsch, M., Loibner, H., Salzberg, M., Bruggisser, M., Penninger, J., & Krähenbühl, S. (2013) · Clinical Pharmacokinetics · doi:10.1007/s40262-013-0072-7 · Cited by 361
Metadata
- Authors
- Ruiz-Ortega, M., Lorenzo, O., Rupérez, M., Esteban, V., Suzuki, Y., Mezzano, S., Plaza, J. J., & Egido, J.
- Venue
- Hypertension
- Published
- 2001-12
- Volume
- 38
- Issue
- 6
- Pages
- 1382-1387
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2132454291
- Cited by
- 308
- References
- 59
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.